Millennium Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.98M | Sell |
|
|||||
|
2025
Q2 | $17.7M | Sell |
|
|||||
|
2025
Q1 | $25.8M | Buy |
|
|||||
|
2024
Q4 | $29.3M | Sell |
|
|||||
|
2024
Q3 | $39.5M | Sell |
|
|||||
|
2024
Q2 | $76.1M | Buy |
|
|||||
|
2024
Q1 | $33.1M | Buy |
|
|||||
|
2023
Q4 | $1.37M | Sell |
|
|||||
|
2023
Q3 | $3.88M | Buy |
|
|||||
|
2023
Q2 | $2.56M | Sell |
|
|||||
|
2023
Q1 | $30.6M | Sell |
|
|||||
|
2022
Q4 | $35.8M | Buy |
|
|||||
|
2022
Q3 | $12.2M | Buy |
|
|||||
|
2022
Q2 | $7.39M | Buy |
|
|||||
|
2022
Q1 | $539K | Sell |
|
|||||
|
2021
Q4 | $5.32M | Sell |
|
|||||
|
2021
Q3 | $9.72M | Sell |
|
|||||
|
2021
Q2 | $53.7M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $290K | Sell |
|
|||||
|
2020
Q3 | $489 | Sell |
|
|||||
|
2020
Q2 | $4.34M | Buy |
|
|||||
|
2020
Q1 | $595K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $248K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.32M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $15.3M | Buy |
|
|||||
|
2017
Q4 | $5.74M | Buy |
|
|||||
|
2017
Q3 | $4.61M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $266K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $709K | Sell |
|
|||||
|
2016
Q2 | $22.6M | Buy |
|
|||||
|
2016
Q1 | $18.1M | Buy |
|
|||||
|
2015
Q4 | $21.8M | Sell |
|
|||||
|
2015
Q3 | $52.2M | Buy |
|
|||||
|
2015
Q2 | $49.6M | Sell |
|
|||||
|
2015
Q1 | $61M | Buy |
|
|||||
|
2014
Q4 | $13.5M | Buy |
|
|||||
|
2014
Q3 | $226K | Sell |
|
|||||
|
2014
Q2 | $644K | Sell |
|
|||||
|
2014
Q1 | $3.82M | Buy |
|